Literature DB >> 10996110

A one-step RT-PCR assay using an enzyme-linked detection system for the diagnosis of enterovirus meningitis.

K A Stellrecht1, I Harding, F M Hussain, N G Mishrik, R T Czap, M L Lepow, R A Venezia.   

Abstract

BACKGROUND: Enteroviruses are the most common cause of meningitis in the United States, with an estimated 50000-75000 cases each year. Enteroviral meningitis (EVM) is frequently a diagnosis of exclusion, as viral cultures lack sensitivity and require prolonged incubation periods.
OBJECTIVE: To develop a sensitive and rapid test for the diagnosis of EVM. STUDY
DESIGN: A rapid, one-step, reverse transcriptase-polymerase chain reaction (RT-PCR) was used in a prospective analysis of 160 patients who had cerebrospinal fluid (CSF) tested for enterovirus.
RESULTS: Of the 160 patients, 14 were excluded due to missing CSF viral culture data. A total of 14 were CSF culture positive (10 with pleocytosis) and 19 were PCR positive (15 with pleocytosis). The ability to detect enterovirus by either culture or PCR correlated significantly with the white blood cell count in the CSF (P=0.001). Based on a clinical definition of enterovirus culture positive and pleocylosis: ten had definite EVM and 12 had probable EVM (pleocytosis without any other cause). Four had possible EVM (CSF culture positive without pleocytosis) and 18 had pleocytosis due to other causes. PCR was positive in all ten patients with definite EVM. Five out of 12 patients with probable EVM and three out of four patients with possible EVM. No patients with pleocytosis due to other causes were PCR positive and one patient that was defined as EVM negative (culture negative and no pleocytosis) was PCR positive. Overall, PCR was positive in 18 out of the 26 patients with a likelihood of EVM, while CSF culture was positive in only 14 cases. Our results demonstrated that RT-PCR enhances the sensitivity of enterovirus detection in CSF (69 vs. 54% for culture).
CONCLUSION: The diagnosis of EVM is difficult to make clinically: the enhanced sensitivity and rapid turn around time of PCR will be of great clinical benefit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996110     DOI: 10.1016/s1386-6532(00)00082-2

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

Review 1.  Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system.

Authors:  Thomas W Smalling; Susan E Sefers; Haijing Li; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients.

Authors:  William S Mulford; Richard S Buller; Max Q Arens; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels.

Authors:  Katja Seme; Tina Mocilnik; Kristina Fujs Komlos; Ana Doplihar; David H Persing; Mario Poljak
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948

4.  Comparison of multiplex PCR assay with culture for detection of genital mycoplasmas.

Authors:  Kathleen A Stellrecht; Amy M Woron; Nada G Mishrik; Richard A Venezia
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control.

Authors:  Marcel Beld; René Minnaar; Jan Weel; Cees Sol; Marjolein Damen; Harry van der Avoort; Pauline Wertheim-van Dillen; Alex van Breda; René Boom
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Comparison of three commercial RT-PCR systems for the detection of respiratory viruses.

Authors:  S A Butt; V P Maceira; M E McCallen; K A Stellrecht
Journal:  J Clin Virol       Date:  2014-08-18       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.